Tayebeh Farhadi

917 total citations · 1 hit paper
29 papers, 660 citations indexed

About

Tayebeh Farhadi is a scholar working on Molecular Biology, Infectious Diseases and Immunology. According to data from OpenAlex, Tayebeh Farhadi has authored 29 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Infectious Diseases and 7 papers in Immunology. Recurrent topics in Tayebeh Farhadi's work include vaccines and immunoinformatics approaches (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Tayebeh Farhadi is often cited by papers focused on vaccines and immunoinformatics approaches (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Tayebeh Farhadi collaborates with scholars based in Iran, Czechia and United States. Tayebeh Farhadi's co-authors include Seyed Mohammad Reza Hashemian, Ali Akbar Velayati, Seyed Mohammadreza Hashemian, Mohammad Mehdi Ranjbar, Younes Ghasemi, Navid Nezafat, Nasrollah Erfani, Shiva Hemmati, Atefeh Fakharian and Mohammad Majid Ebrahimi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Drug Design Development and Therapy and Expert Review of Anti-infective Therapy.

In The Last Decade

Tayebeh Farhadi

27 papers receiving 644 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Linezolid: a review of its properties, function, and use in critical care

2018 300 citations Seyed Mohammad Reza Hashemian, Tayebeh Farhadi et al. Drug Design Development and Therapy profile →

Peers

Tayebeh Farhadi

EPIDE

PHARM

Muhammed A. Bakhrebah Saudi Arabia

Sanil D. Singh South Africa

Masayo Kakuta Japan

Samira Dahesh United States

Sanjay Menon United States

Meena Sachdeva United States

Ekachai Jenwitheesuk Thailand

Bruce D. McCollister United States

Shisong Fang China

Waleed Younis United States

Muhammed A. Bakhrebah Saudi Arabia

Tayebeh Farhadi

234 ×0.8

227 ×0.9

73 ×0.7

EPIDE

38 ×0.4

PHARM

77 ×1.1

Citations per year, relative to Tayebeh Farhadi Tayebeh Farhadi (= 1×) peers Muhammed A. Bakhrebah

Countries citing papers authored by Tayebeh Farhadi

Since Specialization

Citations

This map shows the geographic impact of Tayebeh Farhadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tayebeh Farhadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tayebeh Farhadi more than expected).

Fields of papers citing papers by Tayebeh Farhadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tayebeh Farhadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tayebeh Farhadi. The network helps show where Tayebeh Farhadi may publish in the future.

Co-authorship network of co-authors of Tayebeh Farhadi

This figure shows the co-authorship network connecting the top 25 collaborators of Tayebeh Farhadi. A scholar is included among the top collaborators of Tayebeh Farhadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tayebeh Farhadi. Tayebeh Farhadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hashemian, Seyed Mohammad Reza & Tayebeh Farhadi. (2023). A narrative review on tofacitinib: The properties, function, and usefulness to treat coronavirus disease 2019. International Journal of Critical Illness and Injury Science. 13(4). 192–198. 1 indexed citations

Farhadi, Tayebeh, et al.. (2020). A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19. SHILAP Revista de lepidopterología. 7 indexed citations

Hashemian, Seyed Mohammad Reza, Tayebeh Farhadi, & Ali Akbar Velayati. (2020). <p>A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19</p>. Drug Design Development and Therapy. Volume 14. 3215–3222. 36 indexed citations

Farhadi, Tayebeh, et al.. (2020). A review on favipiravir: the properties, function, and usefulness to treat COVID-19. Expert Review of Anti-infective Therapy. 19(8). 1029–1037. 37 indexed citations

Farhadi, Tayebeh, et al.. (2020). Virtual screening for potential inhibitors of β(1,3)-D-glucan synthase as drug candidates against fungal cell wall. PubMed. 9(1). 52–59. 9 indexed citations

Hashemian, Seyed Mohammad Reza, et al.. (2019). <p>Fosfomycin: the characteristics, activity, and use in critical care</p>. Therapeutics and Clinical Risk Management. Volume 15. 525–530. 26 indexed citations

Hashemian, Seyed Mohammad Reza, et al.. (2018). Linezolid: a review of its properties, function, and use in critical care. Drug Design Development and Therapy. Volume 12. 1759–1767. 300 indexed citations breakdown →

Farhadi, Tayebeh & Seyed Mohammad Reza Hashemian. (2018). Computer-aided design of amino acid-based therapeutics: a review. Drug Design Development and Therapy. Volume 12. 1239–1254. 30 indexed citations

Farhadi, Tayebeh. (2018). Effectiveness assessment of protein drugs and vaccines through in Silico analysis. Biomedical and Biotechnology Research Journal (BBRJ). 2(2). 106–106. 7 indexed citations

10.

Hashemian, Seyed Mohammad Reza, et al.. (2018). Pantaglubulin Usefulness in Critical Care. 4(1).

11.

Farhadi, Tayebeh, et al.. (2017). Virtual Screening for Potential Inhibitors of CTX-M-15 Protein of Klebsiella pneumoniae. Interdisciplinary Sciences Computational Life Sciences. 10(4). 694–703. 15 indexed citations

12.

Fakharian, Atefeh, et al.. (2017). Validation of the COPD Assessment Test in Patients with COPD in Iran. 2(1). 5 indexed citations

13.

Farhadi, Tayebeh. (2017). In silico designing of peptide inhibitors against pregnane X receptor: the novel candidates to control drug metabolism. International Journal of Peptide Research and Therapeutics. 24(3). 409–420. 7 indexed citations

14.

Farhadi, Tayebeh, Atefeh Fakharian, & Seyed Mohammadreza Hashemian. (2017). Affinity Improvement of a Humanized Antiviral Antibody by Structure-Based Computational Design. International Journal of Peptide Research and Therapeutics. 25(1). 181–186. 6 indexed citations

15.

Fakharian, Atefeh, et al.. (2017). Relation between Cor Pulmonale Status and Metrics of Six Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease: A Cross Sectional Study. 2(1).

16.

Farhadi, Tayebeh & Seyed Mohammadreza Hashemian. (2017). Constructing novel chimeric DNA vaccine against Salmonella enterica based on SopB and GroEL proteins: an in silico approach. Journal of Pharmaceutical Investigation. 48(6). 639–655. 12 indexed citations

17.

Farhadi, Tayebeh, et al.. (2016). In silico designing of some agonists of toll-like receptor 5 as a novel vaccine adjuvant candidates. Network Modeling Analysis in Health Informatics and Bioinformatics. 5(1). 16 indexed citations

18.

Farhadi, Tayebeh, et al.. (2015). Production of a novel multi-epitope vaccine based on outer membrane proteins of Klebsiella pneumoniae. SHILAP Revista de lepidopterología. 5 indexed citations

19.

Farhadi, Tayebeh, Navid Nezafat, & Younes Ghasemi. (2015). In silico phylogenetic analysis of Vibrio cholerae isolates based on three housekeeping genes. International Journal of Computational Biology and Drug Design. 8(1). 62–62. 9 indexed citations

20.

Mohkam, Milad, et al.. (2012). Isolation and characterization of antibacterial producing actinomycetes from soil samples of Fars province, Iran. Research in Pharmaceutical Sciences. 7(5). 458. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact